#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell type acute leukaemia Thromboangiitis obliterans Aplastic anaemia Endometrial cancer Osteosarcoma metastatic Piriformis syndrome Follicular lymphoma stage II Cutaneous T-cell lymphoma recurrent Chronic lymphocytic leukaemia recurrent Oesophageal atresia Chronic myeloid leukaemia Progressive familial intrahepatic cholestasis Follicle centre lymphoma follicular grade I II – III refractory Diffuse large B-cell lymphoma refractory Amyloidosis More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Basic Information Idiopathic pulmonary fibrosis – Basic Information Biotinidase deficiency – Life with Disease Hairy cell leukaemia – Treatment Lymphangiosarcoma Chondrosarcoma metastatic – Treatment Progressive multifocal leukoencephalopathy – Basic Information Idiopathic inflammatory myopathy – Treatment Advanced systemic mastocytosis – Trials in Disease Friedreich’s ataxia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glasdegib Buserelin Acetate Minzasolmin Abc-15A-116 Thiamine Cabergoline Deupirfenidone Varenicline Aluminium Hydroxide Dermatophagoides Pteronyssinus AZD4512 Imatinib Dapirolizumab Pegol Dolutegravir Rezpegaldesleukin Olodaterol Sunitinib Oxazepam Gr0015 Aclidinium Bromide More therapies…

    Learn about Your Condition

    Medullary thyroid cancer HIV infection Pathogen resistance Breast proliferative changes Rhabdomyosarcoma recurrent Coronary artery disease Bacterial vaginosis Gastrointestinal carcinoma Habitual abortion Prodromal Alzheimer's disease Dilated cardiomyopathy Pleural mesothelioma malignant Arthroscopy Metastases to lymph nodes Alveolar bone defect More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Bacs-Kiskun Varmegyei Oktatokorhaz

Bacs-Kiskun Varmegyei Oktatokorhaz

Nyiri Ut 38, Kecskemet, 6000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Carboplatin
    • Codeine Phosphate
    Austria Czechia France Germany Hungary Ireland +4

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Gemcitabine Hydrochloride
    • Paclitaxel
    Belgium Czechia France Germany Hungary Poland +2

  • Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Docetaxel
    • Prednisolone
    Belgium France Germany Hungary Italy Poland +1

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Ly3484356
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Finland France Germany +10

  • Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Remibrutinib
    Belgium Bulgaria Czechia France Germany Greece +6

  • A Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Angina pectoris
    Investigated Drugs:
    • 13N-AMMONIA
    Belgium Germany Hungary The Netherlands Poland

  • Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Img-007
    Czechia Germany Hungary Poland Spain

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    • Deucravacitinib
    Germany Hungary Italy Poland Romania Spain
Previous Page
1 … 3 4 5 6 7 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!